América Móvil, S.A.B. de C.V. (AMX) EPS Estimated At $0.50; Achieve Life Sciences Hares (ACHV) Shorts Up By 5.25%

April 17, 2018 - By Richard Conner

Achieve Life Sciences Inc Hares (NASDAQ:ACHV) had an increase of 5.25% in short interest. ACHV’s SI was 663,600 shares in April as released by FINRA. Its up 5.25% from 630,500 shares previously. With 38,700 avg volume, 17 days are for Achieve Life Sciences Inc Hares (NASDAQ:ACHV)’s short sellers to cover ACHV’s short positions. The stock decreased 2.94% or $0.04 during the last trading session, reaching $1.32. About 11,260 shares traded. Achieve Life Sciences, Inc. (NASDAQ:ACHV) has declined 75.05% since April 17, 2017 and is downtrending. It has underperformed by 86.60% the S&P500.

Analysts expect América Móvil, S.A.B. de C.V. (NYSE:AMX) to report $0.50 EPS on April, 24 after the close.They anticipate $0.03 EPS change or 5.66% from last quarter’s $0.53 EPS. AMX’s profit would be $1.59B giving it 9.75 P/E if the $0.50 EPS is correct. After having $-0.16 EPS previously, América Móvil, S.A.B. de C.V.’s analysts see -412.50% EPS growth. The stock decreased 0.86% or $0.17 during the last trading session, reaching $19.49. About 1.61M shares traded. América Móvil, S.A.B. de C.V. (NYSE:AMX) has risen 33.47% since April 17, 2017 and is uptrending. It has outperformed by 21.92% the S&P500.

América Móvil, S.A.B. de C.V. provides telecommunications services in Mexico and internationally. The company has market cap of $62.11 billion. The firm offers wireless and fixed voice services, including airtime, local, domestic, and international long-distance services; and network interconnection services. It has a 40.6 P/E ratio. It also provides data services, such as Internet access, messaging, and other wireless entertainment and corporate services; data transmission, email services, instant messaging, content streaming, and interactive applications; and data center, data administration, and hosting services to residential and corporate clients, as well as residential broadband services.

Among 12 analysts covering America Movil S.A.B. (NYSE:AMX), 7 have Buy rating, 2 Sell and 3 Hold. Therefore 58% are positive. America Movil S.A.B. had 32 analyst reports since July 21, 2015 according to SRatingsIntel. JP Morgan downgraded the stock to “Underweight” rating in Thursday, April 28 report. The firm earned “Underperform” rating on Wednesday, October 21 by RBC Capital Markets. The stock of América Móvil, S.A.B. de C.V. (NYSE:AMX) earned “Hold” rating by Credit Suisse on Wednesday, June 7. As per Tuesday, February 13, the company rating was maintained by Scotia Capital. Bank of America downgraded the stock to “Neutral” rating in Thursday, April 28 report. Citigroup downgraded América Móvil, S.A.B. de C.V. (NYSE:AMX) on Thursday, April 28 to “Sell” rating. Deutsche Bank upgraded the shares of AMX in report on Monday, October 16 to “Buy” rating. The firm has “Equal-Weight” rating by Morgan Stanley given on Friday, December 11. The rating was downgraded by Macquarie Research to “Neutral” on Tuesday, November 17. The firm has “Sell” rating by RBC Capital Markets given on Friday, July 21.

Achieve Life Sciences, Inc., a biopharmaceutical company, develops and commercializes therapies that address treatment resistance in cancer patients. The company has market cap of $16.83 million. It is developing Apatorsen to block the production of heat shock protein 27, a cell-survival protein expressed in various types of cancers, including bladder, prostate, breast, pancreatic, and non-small cell lung cancer. It currently has negative earnings.

América Móvil, S.A.B. de C.V. (NYSE:AMX) Ratings Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>